Press Release
WiseGuyReports.com adds “Breast Cancer Therapeutics Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports to its database.

Breast Cancer Therapeutics Market:

Executive Summary

Breast cancer is one of the most fatal cancer witnessed in women and is the second leading cause of death. It refers to cancer developed in breast tissues. It is caused by genetic mutation in the DNA of breast cancer cells. These are mainly of three types – Human Epidermal Growth Factor Receptor 2 (HER2), Hormone Receptor (HR)-positive and Triple negative breast cancer (TNBC). HR-positive type is the most common type of breast cancer accounting for around three-fourth of total cases. Diagnosis of breast cancer is done by imaging tests such as mammography, followed by biopsy in certain cases. Treatment of breast cancer is dependent upon various factors such as type of breast cancer, stage of the cancer, sensitivity to hormones, patient’s age, etc.

Growth of global breast cancer therapeutics market is attributed to increasing prevalence of breast cancer, ageing population, rapid changes in lifestyle and increasing public awareness. However, the faces several challenges due to various factors such as patent expiration of blockbuster drugs, stringent regulations, lack of awareness in LICs and high prices of therapies.

The report “Global Breast Cancer Therapeutics Market [(By Drug Type – HER2 Inhibitors, CDK4/6 Inhibitors & Aromatase Inhibitors; By Region – North America (The US), Europe (Germany) & Asia Pacific (Japan)] Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global breast cancer market with market segmentation done across major drug types such as HER2 Inhibitors, CDK4/6 Inhibitors & Aromatase Inhibitors. Future forecasts of DNA vaccine market overall and across various regional markets has been provided in the report till 2025. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global breast cancer market include F. Hoffman-La Roche AG, Novartis AG, Eli Lilly and Company, Pfizer Inc., AstraZeneca PLC, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global breast cancer market.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3953665-global-breast-cancer-therapeutics-market-by-drug-type

Table of Contents

1. Executive Summary

2. Research Methodology

3. Breast Cancer
3.1 Overview
3.1.1 Causes
3.1.2 Symptoms
3.1.3 Stages
3.2 Types
3.2.1 Hormone receptor (HR)-positive
3.2.2 Human epidermal growth factor receptor 2 (HER2)-positive
3.2.3 Triple negative breast cancer (TNBC)
3.3 Diagnosis & Treatment
3.3.1 Diagnosis
3.3.2 Treatment

4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Stage
4.2.2 Market Share by Type
4.2.3 Market Share by Region

5. Market Segmentation – Drug Type
5.1 HER2 Inhibitors
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.2 CDK4/6 Inhibitors
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.3 Aromatase Inhibitors
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)

6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US Market Sizing (Actual & Forecasted) Market Share by Drug Types
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 Market by Nations
6.3.3 Japan Market Sizing (Actual & Forecasted) Market Share by Drugs

7. Market Dynamics
7.1 Industry Trends & Developments
7.1.1 Mergers & Acquisitions
7.1.2 Emergence of Novel Therapies
7.1.3 Advent of Personalized & Targeted Therapies
7.2 Growth Drivers
7.2.1 Prevalence of Breast Cancer
7.2.2 Ageing Population
7.2.3 Rapid Changes in Lifestyle
7.2.4 Increasing Public Awareness
7.3 Challenges
7.3.1 Patent Expirations of Blockbuster Drugs
7.3.2 Stringent Regulations
7.3.3 Lack of Awareness in LICs
7.3.4 High Prices of Therapies

8. Competitive Landscape

9. Company Profiles
9.1 F. Hoffman-La Roche AG
9.2 Novartis AG
9.3 Eli Lilly and Company
9.4 Pfizer Inc.
9.5 AstraZeneca PLC


For further information on this report, visit – https://www.wiseguyreports.com/enquiry/3953665-global-breast-cancer-therapeutics-market-by-drug-type


Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com